ENTRY       D02562                      Drug
NAME        Rasagiline mesylate (USAN);
            Rasagiline mesilate (JAN);
            Azilect (TN)
PRODUCT     AZILECT (Teva Neuroscience)
  GENERIC   RASAGILINE (Alvogen)
            RASAGILINE (Ascend Laboratories)
            RASAGILINE (AvKARE)
            RASAGILINE (Micro Labs Limited)
            RASAGILINE (NorthStar RxLLC)
            RASAGILINE (Teva Pharmaceuticals USA)
            RASAGILINE MESYLATE (Avet Pharmaceuticals)
            RASAGILINE MESYLATE (Mylan Pharmaceuticals)
FORMULA     C12H13N. CH4SO3
EXACT_MASS  267.0929
MOL_WEIGHT  267.344
CLASS       Neuropsychiatric agent
             DG01568  MAO inhibitor
              DG01512  Monoamine oxidase B inhibitor
             DG01967  Antiparkinson agent
            Metabolizing enzyme substrate
             DG01892  CYP1A2 substrate
REMARK      Therapeutic category: 1169
            ATC code: N04BD02
            Chemical structure group: DG00865
            Product (DG00865): D02562<JP/US>
EFFICACY    Antiparkinsonian, Monoamine oxidase B (MAO-B) inhibitor
  DISEASE   Parkinson's disease [DS:H00057]
TARGET      MAOB [HSA:4129] [KO:K00274]
  PATHWAY   hsa04726(4129)  Serotonergic synapse
            hsa04728(4129)  Dopaminergic synapse
METABOLISM  Enzyme: CYP1A2 [HSA:1544]
INTERACTION  
STR_MAP     map07027  Antidepressants
            map07057  Antiparkinsonian agents
            map07216  Catecholamine transferase inhibitors
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N04 ANTI-PARKINSON DRUGS
               N04B DOPAMINERGIC AGENTS
                N04BD Monoamine oxidase B inhibitors
                 N04BD02 Rasagiline
                  D02562  Rasagiline mesylate (USAN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antiparkinson Agents
              Monoamine Oxidase B (MAO-B) Inhibitors
               Rasagiline
                D02562  Rasagiline mesylate (USAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              11  Agents affecting central nervous system
               116  Antiparkinsonian agents
                1169  Others
                 D02562  Rasagiline mesylate (USAN); Rasagiline mesilate (JAN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01568  MAO inhibitor
               DG01512  Monoamine oxidase B inhibitor
                DG00865  Rasagiline
                 D02562  Rasagiline mesylate
              DG01967  Antiparkinson agent
               DG00865  Rasagiline
                D02562  Rasagiline mesylate
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               DG00865  Rasagiline
                D02562  Rasagiline mesylate
            Drug classes [BR:br08332]
             Neuropsychiatric agent
              DG01967  Antiparkinson agent
               D02562  Rasagiline mesylate
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Oxidoreductases (EC1)
               Amine oxidases
                MAOB
                 D02562  Rasagiline mesylate (USAN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D02562
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D02562
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D02562
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D02562
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D02562
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01568  MAO inhibitor
               DG01512  Monoamine oxidase B inhibitor
                DG00865  Rasagiline
              DG01967  Antiparkinson agent
               DG00865  Rasagiline
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               DG00865  Rasagiline
DBLINKS     CAS: 161735-79-1
            PubChem: 17396733
            LigandBox: D02562
ATOM        18
            1   C8y C    19.8358  -20.6271
            2   C8y C    19.8358  -19.2233
            3   C8x C    18.6201  -18.5214
            4   C8x C    17.4042  -19.2233
            5   C8x C    17.4042  -20.6271
            6   C8x C    18.6201  -21.3291
            7   C1y C    21.1709  -21.0609
            8   C1x C    21.9961  -19.9252
            9   C1x C    21.1709  -18.7895
            10  N1b N    21.1694  -22.4521
            11  C1b C    22.3845  -23.1554
            12  C3b C    23.5851  -22.4638
            13  C3a C    24.7493  -21.7502
            14  O1d O    30.5752  -19.7146
            15  S4a S    30.5752  -21.1185
            16  C1a C    29.1714  -21.1185
            17  O1d O    31.9791  -21.1185
            18  O1d O    30.5752  -22.5223
BOND        18
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     1   7 1
            8     7   8 1
            9     8   9 1
            10    2   9 1
            11    7  10 1 #Up
            12   10  11 1
            13   11  12 1
            14   12  13 3
            15   14  15 2
            16   15  16 1
            17   15  17 1
            18   15  18 2
///
